2022 SFCR Report
reporting period from €312,9m to € 372,1m. This increase was principally due to the acquisition of the AXA portfolio in October 2022 where a capital injection of €50m was carried out. The SCR increased from € 127,4m to € 147,7m over the reporting period. This change is also principally due to the aforementioned acquisition and subsequent reinsurance applicable on the whole balance sheet of the Company. The absolute MCR of € 66.5m increases by €9,2m compared to year-end 2021. The solvency ratio of